Replies to post #85202 on Innovation Pharmaceuticals Inc (IPIX)

[cabel]

Totally agree Cowboy!

[Ultimate01]

I want to hear about PT "X" and the SPORE Grant and everything else will just be honey on my biscuit.


GO CTIX!!!

[MilesTeg]

Yesterdays info was not bottom line data...

The corresponding 95% confidence intervals around the clinical success rates were 85-100%, 90-100%, 94-100%, and 87-100%, respectively. It is important to note that this Phase 2b study was not powered for statistical comparisons. Nevertheless, because the 95% confidence intervals overlap, these clinical success rates are considered similar. Regulators prefer the use of 95% confidence intervals, rather than p-values, when comparing efficacy rates in clinical trials, as they can provide more information than p-values. A much larger study — such as the kind done in phase 3 — would have the power to make statistical comparisons. - See more at: cellceutix.com/cellceutix-releases-confidence-interval-statistics-showing-clinical-success-rates-for-brilacidin-in-treatment-of-absssi/#sthash.bNoJcUDm.dpuf

A confidence interval study, in this case, is predicting clinical success rates for Brilacidin.It is basically an extrapolation of the top and bottom line data, projected into the future.

http://en.wikipedia.org/wiki/Confidence_interval

Bottom line info will include data for each participant over the course of the entire study, including SAEs, lesion reduction numbers, etc..
This is the data that Leo is planning to drop at the conference in 6 days.

Feel free to correct me if I am mistaken here.